Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Ten Hacken

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Leukemia|December 18, 2018
The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemiaElisa Ten Hacken, Maria Gounari, Paolo Ghia, et al.
Leukemia & Lymphoma|August 7, 2010
How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connectionCristina Scielzo, Elisa Ten Hacken, Maria T S Bertilaccio, et al.
STAR Protocols|September 20, 2023
Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editingElisa Ten Hacken, Michaela Gruber, María Hernández-Sánchez, et al.
Cancer Research|December 5, 2022
Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor ModelsLivius Penter, Elisa Ten Hacken, Jackson Southard, et al.
Blood|January 18, 2013
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemiaElisa ten Hacken, Cristina Scielzo, Maria T S Bertilaccio, et al.
Oncotarget|September 8, 2016
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemiaStefania Fiorcari, Rossana Maffei, Valentina Audrito, et al.
Blood|March 6, 2013
Targeting B-cell anergy in chronic lymphocytic leukemiaBenedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, et al.
Leukemia|December 22, 2019
The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironmentEkaterina Kim, Elisa Ten Hacken, Mariela Sivina, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2016
Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic LeukemiaElisa Ten Hacken, Mariela Sivina, Ekaterina Kim, et al.
Blood Advances|December 8, 2022
Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse modelsElisa ten Hacken, Shanye Yin, Robert Redd, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Leukemia|December 18, 2018
The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemiaElisa Ten Hacken, Maria Gounari, Paolo Ghia, et al.
Leukemia & Lymphoma|August 7, 2010
How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connectionCristina Scielzo, Elisa Ten Hacken, Maria T S Bertilaccio, et al.
STAR Protocols|September 20, 2023
Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editingElisa Ten Hacken, Michaela Gruber, María Hernández-Sánchez, et al.
Cancer Research|December 5, 2022
Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor ModelsLivius Penter, Elisa Ten Hacken, Jackson Southard, et al.
Blood|January 18, 2013
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemiaElisa ten Hacken, Cristina Scielzo, Maria T S Bertilaccio, et al.
Oncotarget|September 8, 2016
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemiaStefania Fiorcari, Rossana Maffei, Valentina Audrito, et al.
Blood|March 6, 2013
Targeting B-cell anergy in chronic lymphocytic leukemiaBenedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, et al.
Leukemia|December 22, 2019
The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironmentEkaterina Kim, Elisa Ten Hacken, Mariela Sivina, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2016
Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic LeukemiaElisa Ten Hacken, Mariela Sivina, Ekaterina Kim, et al.
Blood Advances|December 8, 2022
Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse modelsElisa ten Hacken, Shanye Yin, Robert Redd, et al.
Pageof 5